brand logo

Am Fam Physician. 2012;85(10):950


The article, “End-Stage Renal Disease: Symptom Management and Advance Care Planning” (April 1, 2012, page 705), contained two errors. In Table 3 on page 708, the dosage for fentanyl was incorrectly listed as 12.5 mg. The correct dosage for fentanyl is 12.5 mcg intravenously or subcutaneously every two hours as needed. The brand name Duragesic was also incorrectly added to fentanyl in Table 3, and in several locations throughout the article. Fentanyl should have been listed without a brand name. The online version of this article has been corrected.

Continue Reading

More in AFP

Copyright © 2012 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.